Hello Anon,
I would be interested too if someone has started to pursue this process. We have not had any direct experience or reason to do this yet. But I do understand it is a long and arduous process currently because there is no guidance or operating procedures defined for this process yet. While the EU MDR article described what it is, there is no specifics on how this will be done. Sorry I could not provide any specific information as not needed to pursue this regulatory status pathway yet.
------------------------------
Richard Vincins ASQ-CQA, MTOPRA, RAC
Vice President Global Regulatory Affairs
------------------------------
Original Message:
Sent: 17-May-2023 07:52
From: Anonymous Member
Subject: Expert panel consultation - MDR
This message was posted by a user wishing to remain anonymous
Has anybody used the voluntary consultation with an expert panel as per MDR Article 61(2) ? What has been the experience ? We have a device under development for which we are not sure of the classification and we assume it could be a class III, is there a way the expert advises on the classification and also provides an advice on the clinical pathway?